122 related articles for article (PubMed ID: 4280032)
1. Mixed lymphocyte reactivity of patients with solid tumors.
Harris J; Stewart TH
Oncology; 1974; 30(1):33-42. PubMed ID: 4280032
[No Abstract] [Full Text] [Related]
2. Immunologic impairment in bronchogenic carcinoma: a study of lymphocyte response to phytohemagglutinin.
Han T; Takita H
Cancer; 1972 Sep; 30(3):616-20. PubMed ID: 4342406
[No Abstract] [Full Text] [Related]
3. [Delayed immunity in bronchial cancer: lymphocyte activation in culture with phytohemagglutinins and tuberculin PPD compared with the skin response to tubercular antigens].
Piacentini G; Ferrari S; Megale C; Ippoliti F
Boll Ist Sieroter Milan; 1973; 52(3):230-6. PubMed ID: 4762779
[No Abstract] [Full Text] [Related]
4. Microcytotoxicity assays of tumor immunity in patients with bronchogenic carcinoma correlated with clinical status.
Pierce GE; DeVald B
Cancer Res; 1975 Dec; 35(12):3577-84. PubMed ID: 1192421
[TBL] [Abstract][Full Text] [Related]
5. Specific and non-specific immunologic reactivity of regional lymph-node lymphocytes in human malignancy.
Ambus U; Mavlight GM; Gutterman JU; McBride CM; Hersh EM
Int J Cancer; 1974 Sep; 14(3):291-300. PubMed ID: 4142467
[No Abstract] [Full Text] [Related]
6. [The phenomenon of blastic transformation of lymphocytes in the immunology of neoplastic diseases].
Zhukhina GE
Vopr Onkol; 1972; 18(6):91-6. PubMed ID: 4559304
[No Abstract] [Full Text] [Related]
7. Proceedings: Evaluation of immune status in tumor patients.
Vetto RM; Burger DR; Lilley DP
Arch Surg; 1974 Apr; 108(4):558-60. PubMed ID: 4131415
[No Abstract] [Full Text] [Related]
8. Immunologic assays in lung cancer. Skin tests, lymphocyte blastogenesis, and rosette-forming cell count.
Brugarolas A; Han T; Takita H; Minowada J
N Y State J Med; 1973 Mar; 73(6):747-50. PubMed ID: 4510958
[No Abstract] [Full Text] [Related]
9. In vitro methods of assessing lymphocyte transformation in patients undergoing radiotherapy for bronchogenic cancer.
Jenkins VK; Olson MH; Ellis HN
Tex Rep Biol Med; 1973; 31(1):19-28. PubMed ID: 4708575
[No Abstract] [Full Text] [Related]
10. [T-Lymphocyte shifts in patients with melanoma and bronchogenic carcinoma (author's transl)].
Pichler WJ; Stingl G; Micksche M; Neumann H; Knapp W
Wien Klin Wochenschr; 1976 Nov; 88(21):707-9. PubMed ID: 1087506
[TBL] [Abstract][Full Text] [Related]
11. Abnormal lymphocyte protein synthesis in bronchogenic carcinoma.
Whitcomb ME; Parker RL
Cancer; 1977 Dec; 40(6):3014-8. PubMed ID: 303935
[TBL] [Abstract][Full Text] [Related]
12. Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma.
Eck HP; Drings P; Dröge W
J Cancer Res Clin Oncol; 1989; 115(6):571-4. PubMed ID: 2558118
[TBL] [Abstract][Full Text] [Related]
13. In vitro lymphocyte blastogenesis: a prognostic test in patients with neoplastic disease.
Han T
J Surg Oncol; 1973 Jun; 5(6):567-74. PubMed ID: 4129688
[No Abstract] [Full Text] [Related]
14. [Immunological monitoring of patients operated on for epidermoid bronchogenic carcinoma].
Dominioni L; Dionigi R; Cremaschi P; Nascimbene C; Cividini F; Mori A; Pecis C; Asti S; Moncalvo F; Campani M
Chir Ital; 1981 Feb; 33(1):47-59. PubMed ID: 7261218
[TBL] [Abstract][Full Text] [Related]
15. Lymphocyte subsets in bronchoalveolar lavage fluid and in circulating blood in epidermoid bronchogenic carcinoma.
Piazza G; Marchi E; Scaglione F; Montoli CC; Losi S; Scarpazza G
Respiration; 1990; 57(1):28-36. PubMed ID: 2359893
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of pre-treatment lymphocyte count and T cell levels in localized bronchogenic carcinoma.
Dellon AL; Potvin C; Chretien PB
J Surg Oncol; 1979; 12(3):253-61. PubMed ID: 228122
[TBL] [Abstract][Full Text] [Related]
17. Diminished lymphocyte responses to phytohemagglutinin in lung cancer.
Hadjipetrou-Kourounakis L; Tsougranis A
Biochem Exp Biol; 1980; 16(4):357-64. PubMed ID: 6285942
[TBL] [Abstract][Full Text] [Related]
18. [Suppressor activity induced by concanavalin A in peripheral blood lymphocytes of patients with solid malignant tumors].
García MS; Barañao RI; Fernández O; Rumi LS
Acta Physiol Lat Am; 1983; 33(1):15-20. PubMed ID: 6229133
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro assays of immunocompetence in bronchogenic carcinoma.
Alsabti EA
Oncology; 1979; 36(4):171-5. PubMed ID: 157453
[TBL] [Abstract][Full Text] [Related]
20. Effect of anticancer therapy of lymphocyte cytotoxicity in lung cancer patients.
Manabe H; Yasumoto K; Ohta M; Toyohira K; Nomoto K
Gan; 1977 Aug; 68(4):477-82. PubMed ID: 357239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
